SUMMARY The proteinase inhibitor null (Pi-) allele is a rare cause of a1 antitrypsin (AAT) deficiency. In three families, all the subjects with AAT deficiency due to PiZ- Pi-(fig 3) . With XbaI, the size of the DNA fragments in the normal allele were 13-3 kb, 4-7 kb, and 2-4 kb, while subjects with the polymorphism had an additional band of 7-1 kb when their DNA was probed with pAT 6-5 (fig 3) . The 7-1 kb band was consistent with the deletion of an XbaI site in intron IV (fig 5) . The probable site for the mutation was confirmed by detection of the 7-1 kb band with a cDNA probe NJ which normally detects a 4-7 kb fragment at the 3' end of the gene. Because of the rarity of the Pi-allele it will be difficult to establish the frequency with which the XbaI polymorphism occurs in association with the Pi-allele.
Discussion
We describe three families with the Pi-allele in whom all members with the Pi type Z-have unusually early manifestations of respiratory disease associated with AAT deficiency. The occurrence of repeated chest infections in early childhood has not been previously documented in association with AAT deficiency. In a four year prospective Swedish study of 183 AAT deficient children, predominantly Sweden.16 In the families we have described, the presentation of recurrent chest infections may have been due to passive smoking which is thought to be associated with an increased incidence of respiratory tract infection.'7 In all three families either one or both the parents were active smokers and in combination with AAT deficiency may contribute to early lung damage. There was some evidence of liver dysfunction in three of the four patients, presumably related to the Z allele they have inherited. Pi-deficiency is not usually associated with liver disease but there are insufficient data for an association to be excluded.
In agreement with previous reports we confirm that subjects with the Pi-allele do not show a detectable partial or complete deletion of the AAT gene. 18 By electrophoresis in agarose gels it is difficult to separate DNA fragments which differ in size by a few nucleotides, so it is not possible to exclude totally a small deletion in the gene. In the families we have studied this possibility seems unlikely, as the use of a number of restriction enzymes which recognise DNA sequences in the AAT gene show identical patterns in the Pi-and Pi M alleles. It is still possible that a small deletion is present that cannot be resolved by current techniques. It seems probable that the Pi-allele results from a single point mutation in a critical region of the AAT gene and the abnormality may not be the same for all those with the Pi-allele. The deletion of the XbaI site in the AAT gene can be explained by a mutation in an intron sequence of the gene. As the polymorphism segregates with the Ml allele in one of the families, it seems likely that the null allele may have arisen from Ml and also that the polymorphism per se is not associated with decreased production of AAT.
It is also clear that there may be heterogeneity of Pi-since the XbaI polymorphism does not occur in another family with the allele. Currently, only family studies can confirm the presence of Pi-and better tests based on direct analysis of the gene should facilitate diagnosis. Although the frequency of the Pi-allele in the United Kingdom is not known, if there is a similar frequency to that observed in the American population, the incidence of PiZ-in the United Kingdom is about 1 in 500 000.
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